Saturday, May 23, 2020 6:22:05 PM
"Additional drug delivery development work (e.g.,intranasal/nebulizeddosing, the use of nanotechnologies8) may further complement Brilacidin’s anti-COVID-19 therapeutic potential"
http://www.ipharminc.com/brilacidin-1 pg 19
Due to the immunomodulating abilities of B it has been mentioned as a treatment for Asthma and Copd even back in the Polymedix days. IPIX has infrequently mentioned B as an inhaler recently as a treatment for pulmonary disorders.In the Brilacidin for covid 19 pdf, IPIX affirms an aerosol is a possible area for future study. I am not aware of any current plans to develop an aerosol at this time
10% of the Covid pt have GI complaints so I guess it could b given as a treatment for gastroenteritis.
B is not absorbed systemically so it is unlikely a pill would be effective.
Good luck,Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM